Engineered Bacteria: General Overview as Therapeutic Agent and a Novel Drug Delivery System

Area of Science:

• Biotechnology
• Microbiology
• Genetic Engineering

Background:

• Bacterial engineering involves modifying bacterial genomes for therapeutic applications.
• Engineered bacteria can produce biomolecules, target tissues, and deliver drugs.

Purpose of the Study:

• To review the applications of engineered bacteria in treating various medical conditions.
• To highlight common bacterial strains used in drug delivery and their therapeutic potential.
• To identify limitations and future research directions for bacterial-based therapies.

Main Methods:

• Review of existing literature on bacterial engineering and its applications.
• Identification of commonly studied bacterial strains (e.g., L. lactis, S. typhi, E. coli Nissle).
• Analysis of therapeutic applications in cancer, autoimmune, metabolic, and inflammatory diseases.

Main Results:

• Engineered bacteria demonstrate potential for targeted drug delivery and treatment of multifactorial diseases.
• Key strains like Lactococcus lactis, Salmonella typhi, and E. coli Nissle are established drug carriers.
• Other promising strains include Bifidobacterium animalis and Clostridium sporogenes.

Conclusions:

• Bacterial engineering offers a promising platform for novel therapeutic strategies.
• Challenges include potential toxicity and immune clearance, necessitating combination therapies.
• Further research is crucial to optimize bacterial-based drug delivery systems.